Natural Alternatives International (NAII) Competitors $4.24 +0.10 (+2.42%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NAII vs. ANRO, IMUX, SKYE, MNOV, CNTX, AVTX, PYXS, IPSC, ORMP, and GNTAShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Alto Neuroscience (ANRO), Immunic (IMUX), Skye Bioscience (SKYE), MediciNova (MNOV), Context Therapeutics (CNTX), Avalo Therapeutics (AVTX), Pyxis Oncology (PYXS), Century Therapeutics (IPSC), Oramed Pharmaceuticals (ORMP), and Genenta Science (GNTA). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Alto Neuroscience Immunic Skye Bioscience MediciNova Context Therapeutics Avalo Therapeutics Pyxis Oncology Century Therapeutics Oramed Pharmaceuticals Genenta Science Natural Alternatives International (NASDAQ:NAII) and Alto Neuroscience (NYSE:ANRO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends. Which has preferable earnings & valuation, NAII or ANRO? Natural Alternatives International has higher revenue and earnings than Alto Neuroscience. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$112.98M0.23-$7.22M-$1.44-2.94Alto Neuroscience$210K499.59-$36.31MN/AN/A Does the media favor NAII or ANRO? In the previous week, Alto Neuroscience had 5 more articles in the media than Natural Alternatives International. MarketBeat recorded 5 mentions for Alto Neuroscience and 0 mentions for Natural Alternatives International. Alto Neuroscience's average media sentiment score of 0.28 beat Natural Alternatives International's score of 0.00 indicating that Alto Neuroscience is being referred to more favorably in the news media. Company Overall Sentiment Natural Alternatives International Neutral Alto Neuroscience Neutral Do analysts prefer NAII or ANRO? Alto Neuroscience has a consensus target price of $20.00, suggesting a potential upside of 414.14%. Given Alto Neuroscience's stronger consensus rating and higher probable upside, analysts clearly believe Alto Neuroscience is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Alto Neuroscience 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63 Does the MarketBeat Community favor NAII or ANRO? Natural Alternatives International received 244 more outperform votes than Alto Neuroscience when rated by MarketBeat users. However, 82.35% of users gave Alto Neuroscience an outperform vote while only 75.66% of users gave Natural Alternatives International an outperform vote. CompanyUnderperformOutperformNatural Alternatives InternationalOutperform Votes25875.66% Underperform Votes8324.34% Alto NeuroscienceOutperform Votes1482.35% Underperform Votes317.65% Is NAII or ANRO more profitable? Alto Neuroscience has a net margin of 0.00% compared to Natural Alternatives International's net margin of -7.53%. Natural Alternatives International's return on equity of -10.23% beat Alto Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-7.53% -10.23% -5.38% Alto Neuroscience N/A -49.28%-33.52% Do institutionals & insiders believe in NAII or ANRO? 32.4% of Natural Alternatives International shares are owned by institutional investors. 20.9% of Natural Alternatives International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryAlto Neuroscience beats Natural Alternatives International on 8 of the 15 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.28M$378.07M$5.14B$9.08BDividend YieldN/AN/A5.09%4.23%P/E Ratio-2.9432.5990.0517.18Price / Sales0.236.081,117.14116.99Price / CashN/A10.6643.0437.86Price / Book0.321.884.784.78Net Income-$7.22M-$50.37M$120.31M$225.60M7 Day Performance-1.40%-3.56%-1.92%-1.23%1 Month Performance-0.24%-7.00%11.51%3.36%1 Year Performance-35.85%-6.41%30.61%16.60% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives InternationalN/A$4.24+2.4%N/A-37.1%$26.28M$112.98M-2.94290Analyst ForecastANROAlto Neuroscience3.2643 of 5 stars$3.84+0.3%$20.00+420.8%N/A$103.57M$210,000.000.00N/AGap UpIMUXImmunic2.933 of 5 stars$1.14+0.9%$11.80+935.0%-20.6%$102.70MN/A-0.9270Positive NewsSKYESkye Bioscience2.1841 of 5 stars$3.38+0.9%$18.67+452.3%-10.6%$102.54MN/A0.0011News CoveragePositive NewsGap DownMNOVMediciNova2.1642 of 5 stars$2.09-0.5%$9.00+330.6%+43.7%$102.51M$1M-9.9510Analyst ForecastPositive NewsCNTXContext Therapeutics2.9747 of 5 stars$1.36-2.5%$6.80+401.8%+1.0%$101.62MN/A-1.477Positive NewsGap DownAVTXAvalo Therapeutics3.7075 of 5 stars$9.73+5.4%N/A-13.7%$101.13M$820,000.000.0040Analyst ForecastNews CoveragePositive NewsPYXSPyxis Oncology2.1397 of 5 stars$1.68+3.4%$10.00+497.0%-2.9%$99.61MN/A-1.5760Analyst ForecastNews CoveragePositive NewsIPSCCentury Therapeutics1.8159 of 5 stars$1.17-4.5%$11.60+895.7%-52.6%$99.06M$2.68M-0.66170Gap DownHigh Trading VolumeORMPOramed Pharmaceuticals1.6775 of 5 stars$2.41-2.4%N/A+8.2%$97.15M$1.34M22.4510Analyst UpgradePositive NewsGNTAGenenta Science2.9543 of 5 stars$5.30+3.3%$25.00+371.7%+0.2%$96.94MN/A0.007News CoverageGap Up Related Companies and Tools Related Companies Alto Neuroscience Competitors Immunic Competitors Skye Bioscience Competitors MediciNova Competitors Context Therapeutics Competitors Avalo Therapeutics Competitors Pyxis Oncology Competitors Century Therapeutics Competitors Oramed Pharmaceuticals Competitors Genenta Science Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NAII) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAII Stock Alerts